ASTRAZENECA PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 13.4%

Tue, 22 Sep

ASTRAZENECA PHARMA has announced its results for the quarter ended June 2020. Here is a detailed performance review of the same:

ASTRAZENECA PHARMA Quarterly Financials

No. of Mths Qtr. Ending		3 Jun-19*	3 Mar-20*	3 Jun-20*	QoQ Change	YoY Change
Net Sales	Rs m	2,046	1,949	1,936	-0.7%	-5.4%
Other income	Rs m	30	34	26	-21.6%	-11.4%
Turnover	Rs m	2,076	1,983	1,962	-1.0%	-5.5%
Expenses	Rs m	1,690	1,801	1,650	-8.4%	-2.4%
Gross profit	Rs m	356	148	286	92.9%	-19.7%
Depreciation	Rs m	46	45	46	0.4%	-1.4%
Interest	Rs m	3	3	3	-4.2%	-7.1%
Profit before tax	Rs m	336	134	264	97.6%	-21.5%
Tax	Rs m	121	38	78	105.4%	-36.0%
Profit after tax	Rs m	215	96	186	94.5%	-13.4%
Gross profit margin	%	17.4	7.6	14.8
Effective tax rate	%	36.0	28.3	29.4
Net profit margin	%	10.4	4.8	9.5

Year-on-Year Performance:

• The company's operating income during the quarter fell 5.4% on a year-on-year (YoY) basis. The expenses were down by 2.4% YoY during the same period.
• The company's operating profit declined by 19.7% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 14.8% in 1QFY21 as against 17.4% in 1QFY20.
• Depreciation charges declined by 1.4% and finance costs declined by 7.1% YoY, respectively.
• Other income declined by 11.4% YoY during the quarter.
• Net profit for the quarter declined by 13.4% YoY. Net profit margins during the quarter declined from 10.4% in 1QFY20 to 9.5% in 1QFY21.

Quarter-on-Quarter Performance:

• The company's operating income during the quarter fell 0.7% on a quarter-on-quarter (QoQ) basis. The expenses were down by 8.4% QoQ during the same period.
• The company's operating profit increased by 92.9% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 14.8% in 1QFY21 as against 7.6% in 4QFY20.
• Net profit for the quarter increased by 94.5% QoQ, while net profit margins increased from 4.8% in 4QFY20 to 9.5% in 1QFY21.

To see how ASTRAZENECA PHARMA has performed over the last eight quarters,please visit here.

ASTRAZENECA PHARMA Share Price Performance

Over the last one year, ASTRAZENECA PHARMA share price has moved up from Rs 2,048.8 to Rs 4,286.5, registering a Gain of Rs 2,237.7 or around 109.2%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 19,200.0 (down 2.1%). Over the last one year it has moved up from 13,016.6 to 19,200.0, a gain of 6,183 points (up 47.5%).

Overall, the S&P BSE SENSEX is up 3.3% over the year.

Current Valuations

At the current price of Rs 4,286.5, the price to earnings (P/E) ratio of ASTRAZENECA PHARMA stands at 154.6 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 43.4 times.